☰

Min Z. Levine, Ph.D. - Publications

Affiliations: 
2001 Georgia State University, Atlanta, GA, United States 
Area:
Chemical senses
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Liu F, Gross FL, Joshi S, Gaglani M, Naleway AL, Murthy K, Groom HC, Wesley MG, Edwards LJ, Grant L, Kim SS, Sambhara S, Gangappa S, Tumpey T, Thompson MG, ... ... Levine MZ, et al. Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines. Nature Communications. 15: 254. PMID 38177116 DOI: 10.1038/s41467-023-44551-x  0.328
2023 Guo Z, Lu X, Carney PJ, Chang J, Tzeng WP, York IA, Levine MZ, Stevens J. Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010-2011 Influenza Seasonal Vaccine. Vaccines. 11. PMID 37631875 DOI: 10.3390/vaccines11081307  0.352
2023 Naleway AL, Kim SS, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards LJ, Ball S, Grant L, Zunie T, Cao W, Gross FL, Groom H, Fry AM, et al. Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020. Open Forum Infectious Diseases. 10: ofad223. PMID 37305842 DOI: 10.1093/ofid/ofad223  0.302
2023 Williams KV, Li ZN, Zhai B, Alcorn JF, Nowalk MP, Levine MZ, Kim SS, Flannery B, Moehling Geffel K, Merranko AJ, Collins M, Susick M, Clarke KS, Zimmerman RK, Martin JM. A randomized controlled trial to compare immunogenicity to cell-based vs. live-attenuated influenza vaccines in children. Journal of the Pediatric Infectious Diseases Society. PMID 37232430 DOI: 10.1093/jpids/piad033  0.311
2022 Levine MZ, Holiday C, Bai Y, Zhong W, Liu F, Jefferson S, Gross FL, Tzeng WP, Fries L, Smith G, Boutet P, Friel D, Innis BL, Mallett CP, Davis CT, et al. Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity. Vaccines. 10. PMID 36366364 DOI: 10.3390/vaccines10111856  0.31
2022 Gaglani M, Kim SS, Naleway AL, Levine MZ, Edwards L, Murthy K, Dunnigan K, Zunie T, Groom H, Ball S, Jeddy Z, Hunt D, Wesley MG, Sambhara S, Gangappa S, et al. Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36031405 DOI: 10.1093/cid/ciac683  0.304
2022 Li ZN, Liu F, Jefferson S, Horner L, Carney P, Johnson MDL, King JP, Martin ET, Zimmerman RK, Wernli K, Gaglani M, Thompson M, Flannery B, Stevens J, Tumpey T, ... Levine MZ, et al. Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35684961 DOI: 10.1093/cid/ciac472  0.327
2022 Williams KV, Zhai B, Alcorn JF, Patricia Nowalk M, Levine MZ, Kim SS, Flannery B, Moehling Geffel K, Jaber Merranko A, Nagg JP, Collins M, Susick M, Clarke KS, Zimmerman RK, Martin JM. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults. Vaccine. 40: 780-788. PMID 34952751 DOI: 10.1016/j.vaccine.2021.12.034  0.315
2021 Liu F, Gross FL, Jefferson SN, Holiday C, Bai Y, Wang L, Zhou B, Levine MZ. Age-specific effects of vaccine egg-adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination. The Journal of Clinical Investigation. PMID 33690218 DOI: 10.1172/JCI146138  0.306
2021 Li ZN, Liu F, Gross FL, Kim L, Ferdinands J, Carney P, Chang J, Stevens J, Tumpey T, Levine MZ. Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay. Mbio. 12. PMID 33531397 DOI: 10.1128/mBio.02808-20  0.337
2020 Moehling KK, Zhai B, Schwarzmann WE, Chandran UR, Ortiz M, Nowalk MP, Nace D, Lin CJ, Susick M, Levine MZ, Alcorn JF, Zimmerman RK. The impact of physical frailty on the response to inactivated influenza vaccine in older adults. Aging. 12. PMID 33347425 DOI: 10.18632/aging.202207  0.309
2020 Hinojosa M, Shepard SS, Chung JR, King JP, McLean HQ, Flannery B, Belongia EA, Levine MZ. Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children. The Journal of Infectious Diseases. PMID 33090202 DOI: 10.1093/infdis/jiaa665  0.311
2020 Wang W, Alvarado-Facundo E, Vassell R, Collins L, Colombo RE, Ganesan A, Geaney C, Hrncir D, Lalani T, Markelz AE, Maves RC, McClenathan B, Mende K, Richard SA, Schofield C, ... ... Levine M, et al. Comparison of A(H3N2) neutralizing antibody responses elicited by 2018-2019 season quadrivalent influenza vaccines derived from eggs, cells, and recombinant hemagglutinin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32898271 DOI: 10.1093/cid/ciaa1352  0.334
2020 Wesley MG, Soto G, Arriola CS, Gonzales M, Newes-Adeyi G, Romero C, Veguilla V, Levine MZ, Silva M, Ferdinands JM, Dawood FS, Reynolds SB, Hirsch A, Katz M, Matos E, et al. Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016-2018. Influenza and Other Respiratory Viruses. PMID 32249553 DOI: 10.1111/irv.12737  0.311
2020 Belongia EA, Levine MZ, Olaiya O, Gross FL, King JP, Flannery B, McLean HQ. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018. Vaccine. PMID 32145994 DOI: 10.1016/j.vaccine.2020.02.055  0.303
2019 Music N, Tzeng WP, Liaini Gross F, Levine MZ, Xu X, Shieh WJ, Tumpey TM, Katz JM, York IA. Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets. Npj Vaccines. 4: 28. PMID 31312528 DOI: 10.1038/s41541-019-0123-7  0.319
2019 Zhong W, Levine MZ. Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses. The Journal of Infectious Diseases. PMID 31169293 DOI: 10.1093/infdis/jiz295  0.318
2019 Levine MZ, Holiday C, Jefferson S, Gross FL, Liu F, Li S, Friel D, Boutet P, Innis BL, Mallett CP, Tumpey TM, Stevens J, Katz JM. Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost. Npj Vaccines. 4: 22. PMID 31149353 DOI: 10.1038/s41541-019-0114-8  0.327
2019 Levine MZ, Martin ET, Petrie JG, Lauring AS, Holiday C, Jefferson S, Fitzsimmons WJ, Johnson E, Ferdinands JM, Monto AS. Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season. The Journal of Infectious Diseases. PMID 30721982 DOI: 10.1093/Infdis/Jiz049  0.334
2018 Pratt CQ, Zhu Y, Grijalva CG, Wunderink RG, Courtney DM, Waterer G, Levine MZ, Jefferson S, Self WH, Williams DJ, Finelli L, Bramley AM, Edwards KM, Jain S, Anderson EJ. Serological Response to Influenza Vaccination Among Adults Hospitalized with Community Acquired Pneumonia. Influenza and Other Respiratory Viruses. PMID 30485702 DOI: 10.1111/irv.12622  0.313
2018 Hirsch A, Katz MA, Laufer Peretz A, Greenberg D, Wendlandt R, Shemer Avni Y, Newes-Adeyi G, Gofer I, Leventer-Roberts M, Davidovitch N, Rosenthal A, Gur-Arie R, Hertz T, Glatman-Freedman A, Monto AS, ... ... Levine M, et al. Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol. Bmc Infectious Diseases. 18: 550. PMID 30400834 DOI: 10.1186/S12879-018-3444-7  0.313
2018 Liu F, Tzeng WP, Horner L, Kamal RP, Tatum HR, Blanchard EG, Xu X, York I, Tumpey TM, Katz JM, Lu X, Levine MZ. Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults. The Journal of Infectious Diseases. PMID 29931203 DOI: 10.1093/Infdis/Jiy376  0.32
2017 Gross FL, Bai Y, Jefferson S, Holiday C, Levine MZ. Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells. Journal of Visualized Experiments : Jove. PMID 29286446 DOI: 10.3791/56448  0.3
2017 Levine MZ, Holiday C, Liu F, Jefferson S, Gillis E, Bellamy AR, Tumpey T, Katz JM. Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans. The Journal of Infectious Diseases. 216: S555-S559. PMID 28934456 DOI: 10.1093/Infdis/Jix001  0.328
2017 Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA. Inactivated H7 influenza virus vaccines protect mice despite low levels of neutralizing antibodies. Journal of Virology. PMID 28768855 DOI: 10.1128/Jvi.01202-17  0.308
2017 Smith GE, Sun X, Bai Y, Liu YV, Massare MJ, Pearce MB, Belser JA, Maines TR, Creager HM, Glenn GM, Flyer D, Pushko P, Levine MZ, Tumpey TM. Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets. Virology. 509: 90-97. PMID 28624679 DOI: 10.1016/J.Virol.2017.06.006  0.318
2017 Sun X, Belser JA, Pulit-Penaloza JA, Creager HM, Guo Z, Jefferson SN, Liu F, York IA, Stevens J, Maines TR, Jernigan DB, Katz JM, Levine MZ, Tumpey TM. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets. Virology. 508: 164-169. PMID 28554058 DOI: 10.1016/J.Virol.2017.05.010  0.331
2016 Levine MZ, Martin JM, Gross FL, Jefferson S, Cole KS, Archibald C, Nowalk MP, Susick M, Moehling K, Spencer S, Chung JR, Flannery B, Zimmerman RK. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) viruses Among Children and Adolescents Following 2014-15 Inactivated and Live Attenuated Influenza Vaccination. Clinical and Vaccine Immunology : Cvi. PMID 27558294 DOI: 10.1128/CVI.00297-16  0.32
2016 Zhong W, Liu F, Wilson JR, Holiday C, Li ZN, Bai Y, Tzeng WP, Stevens J, York IA, Levine MZ. Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans. Open Forum Infectious Diseases. 3: ofw102. PMID 27419174 DOI: 10.1093/Ofid/Ofw102  0.351
2016 Thompson MG, Gaglani MJ, Naleway AL, Dowell SH, Spencer S, Ball S, Levine M, Fry A. Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees. Vaccine. PMID 27195761 DOI: 10.1016/j.vaccine.2016.04.085  0.306
2016 Petrie JG, Ohmit SE, Truscon R, Johnson E, Braun TM, Levine MZ, Eichelberger MC, Monto AS. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season. The Journal of Infectious Diseases. PMID 27095420 DOI: 10.1093/Infdis/Jiw105  0.308
2016 Liu F, Sun X, Fairman J, Lewis DB, Katz JM, Levine M, Tumpey TM, Lu X. A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets. Virology. 492: 197-203. PMID 26967975 DOI: 10.1016/J.Virol.2016.02.024  0.323
2016 Zhong W, Gross FL, Holiday C, Jefferson SN, Bai Y, Liu F, Katz JM, Levine MZ. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans. Viral Immunology. PMID 26950058 DOI: 10.1089/vim.2016.0003  0.327
2016 Thompson MG, Naleway A, Fry AM, Ball S, Spencer SM, Reynolds S, Bozeman S, Levine M, Katz JM, Gaglani M. Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. Vaccine. 34: 981-8. PMID 26813801 DOI: 10.1016/J.Vaccine.2015.10.119  0.302
2015 Mallett CP, Beaulieu E, Joly MH, Baras B, Lu X, Liu F, Levine MZ, Katz JM, Innis BL, Giannini SL. AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes. Vaccine. PMID 26100923 DOI: 10.1016/J.Vaccine.2015.06.053  0.318
2015 Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ. Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel. Open Forum Infectious Diseases. 2: ofu115. PMID 25884004 DOI: 10.1093/ofid/ofu115  0.343
2015 Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. The Journal of Infectious Diseases. PMID 25858957 DOI: 10.1093/Infdis/Jiv195  0.322
2014 Babu TM, Levine M, Fitzgerald T, Luke C, Sangster MY, Jin H, Topham D, Katz J, Treanor J, Subbarao K. Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine. Vaccine. 32: 6798-804. PMID 25446831 DOI: 10.1016/J.Vaccine.2014.09.070  0.316
2014 Li ZN, Carney PJ, Lin SC, Li J, Chang JC, Veguilla V, Stevens J, Miller JD, Levine M, Katz JM, Hancock K. Improved specificity and reduced subtype cross-reactivity for antibody detection by ELISA using globular head domain recombinant hemagglutinin. Journal of Virological Methods. 209: 121-5. PMID 25239367 DOI: 10.1016/J.Jviromet.2014.09.006  0.347
2007 Mayta H, Hancock K, Levine MZ, Gilman RH, Farfán MJ, Verastegui M, Lane WS, Garcia HH, Gonzalez AE, Tsang VC. Characterization of a novel Taenia solium oncosphere antigen. Molecular and Biochemical Parasitology. 156: 154-61. PMID 17850901 DOI: 10.1016/J.Molbiopara.2007.07.017  0.343
Show low-probability matches.